David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

The Case for GOOG Stock Hitting $150 in 2023

By David Moadel, InvestorPlace Contributor

GOOG stock didn't tank when Alphabet announced job cuts, as investors understood that cost reductions aren't a sign of fundamental problems.

Why Is MicroAlgo (NASDAQ:MLGO) Stock Up 110% Today?

By David Moadel, InvestorPlace Contributor

MicroAlgo's plan to generate millions of dollars by selling shares is putting MLGO stock traders in a buying mood today.

Is ARVL Stock a Good Buy? Here’s My Call.

By David Moadel, InvestorPlace Contributor

ARVL stock could actually head toward zero as Arrival provides big talk about a U.S. venture but continues to dig a deep financial hole.

Is Carvana (CVNA) Stock a Buy or Sell? Here’s My Call.

By David Moadel, InvestorPlace Contributor

Some CVNA stock traders may have applauded Carvana's asset preservation tactic, but they shouldn't ignore the company's financial problems.

Why Is First Wave BioPharma (FWBI) Stock Up 30% Today?

By David Moadel, InvestorPlace Contributor

FWBI stock traders are in a buying mood today as First Wave BioPharma adds to its body of medical patent applications.

Why Are Solar Stocks RUN, SPWR, ENPH Down Today?

By David Moadel, InvestorPlace Contributor

Could there be a reset in the U.S. residential solar market this year? This and other concerns are weighing heavily on solar stocks today.

Lululemon (LULU) Stock Dips 3% on Analyst Downgrade

By David Moadel, InvestorPlace Contributor

LULU stock is under pressure today as one of Wall Street's experts warns of a closing of the "expectations vs. reality gap" for Lululemon.

Why Is Baudax Bio (BXRX) Stock Up 50% Today?

By David Moadel, InvestorPlace Contributor

BXRX stock is soaring today as Baudax Bio's novel medical product could result in time and cost savings for patients and hospitals.

Is NIO Stock a Buy or Sell? Here’s My Call.

By David Moadel, InvestorPlace Contributor

NIO stock could revisit its peak price as the automaker prepares to venture into a new and potentially lucrative product market.

TSLA Stock Forecast: Where Will Tesla Be in 5 Years?

By David Moadel, InvestorPlace Contributor

Cathie Wood is standing by her stake in TSLA stock, and Tesla's recent price-reduction strategy could result in a huge long-term payoff.

Load More